• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉血栓栓塞症幸存者的自评健康状况:一项患病率研究。

Self-rated health in venous thromboembolism survivors: a prevalence study.

作者信息

Viuff Jakob Hansen, Martiny Søren Korsgaard, Fuglsang Cecilia Hvitfeldt, Kristensen Frederik Pagh Bredahl, Pedersen Lars, Sørensen Henrik Toft

机构信息

Department of Clinical Epidemiology, Center for Population Medicine, Aarhus University Hospital, Aarhus University, Aarhus, Denmark.

Department of Clinical Epidemiology, Center for Population Medicine, Aarhus University Hospital, Aarhus University, Aarhus, Denmark.

出版信息

J Thromb Haemost. 2025 May 9. doi: 10.1016/j.jtha.2025.04.027.

DOI:10.1016/j.jtha.2025.04.027
PMID:40349923
Abstract

BACKGROUND

Venous thromboembolism (VTE) has both short- and long-term health impacts. Knowledge about self-rated health (SRH) in survivors of VTE remains scarce.

OBJECTIVES

We examined the prevalence of poor SRH in VTE survivors compared with that in persons without VTE.

METHODS

We conducted a prevalence study using the Better Health in Late Life cohort of Danish residents aged 50 to 65 years, enrolled between 2021 and 2022. Participants completed an online questionnaire, and the data were linked to Danish population-based health registries. Information on previous VTE diagnosis was retrieved from the Danish National Patient Registry. Using modified Poisson regression models, we estimated adjusted prevalence proportion ratios (PRs) and prevalence proportion differences to quantify differences in the prevalence of poor SRH among VTE survivors and persons without VTE.

RESULTS

Our study included 113 658 individuals, among whom 2633 (2.3%) were VTE survivors. The prevalence of poor SRH was 31.6% in VTE survivors and 16.2% in participants without VTE, corresponding to a 1.85 (95% CI, 1.75-1.96) times higher prevalence of poor SRH. Compared with people without VTE, the PR was highest in VTE survivors with pulmonary embolism or provoked VTE. The PR remained elevated in comorbidity strata and in those diagnosed with VTE >10 years before questionnaire completion.

CONCLUSION

VTE survivors had nearly a 2-fold increased prevalence of poor SRH compared with those without VTE. This association persisted across VTE subtypes, comorbidity strata, and in those with a distant VTE diagnosis, suggesting long-term implications of VTE on SRH.

摘要

背景

静脉血栓栓塞症(VTE)对健康有短期和长期影响。关于VTE幸存者自评健康(SRH)的知识仍然匮乏。

目的

我们研究了VTE幸存者中SRH较差的患病率,并与无VTE者进行比较。

方法

我们使用2021年至2022年招募的50至65岁丹麦居民的晚年健康状况更好队列进行了一项患病率研究。参与者完成了一份在线问卷,数据与丹麦基于人群的健康登记处相关联。先前VTE诊断的信息从丹麦国家患者登记处获取。使用改良的泊松回归模型,我们估计了调整后的患病率比例比(PRs)和患病率比例差异,以量化VTE幸存者和无VTE者中SRH较差的患病率差异。

结果

我们的研究包括113658人,其中2633人(2.3%)为VTE幸存者。VTE幸存者中SRH较差的患病率为31.6%,无VTE的参与者中为16.2%,SRH较差的患病率高出1.85倍(95%CI,1.75 - 1.96)。与无VTE的人相比,患有肺栓塞或诱因性VTE的VTE幸存者的PR最高。在合并症分层以及在问卷完成前10年以上被诊断为VTE的人群中,PR仍然升高。

结论

与无VTE者相比,VTE幸存者中SRH较差的患病率增加了近两倍。这种关联在VTE亚型、合并症分层以及有远期VTE诊断的人群中均持续存在,表明VTE对SRH有长期影响。

相似文献

1
Self-rated health in venous thromboembolism survivors: a prevalence study.静脉血栓栓塞症幸存者的自评健康状况:一项患病率研究。
J Thromb Haemost. 2025 May 9. doi: 10.1016/j.jtha.2025.04.027.
2
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
3
Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院内科和外科患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2013 Jul 16(7):CD008201. doi: 10.1002/14651858.CD008201.pub2.
4
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.对无诱因静脉血栓栓塞症(VTE)患者进行癌症检测对癌症及VTE相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3.
5
Statins for the primary prevention of venous thromboembolism.他汀类药物用于预防静脉血栓栓塞症的一级预防。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD014769. doi: 10.1002/14651858.CD014769.pub2.
6
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.药物干预预防接受减重手术人群的静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2.
7
Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.不明原因静脉血栓栓塞症(VTE)患者中,检测癌症对癌症或静脉血栓栓塞症(VTE)相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2021 Oct 1;10(10):CD010837. doi: 10.1002/14651858.CD010837.pub5.
8
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
9
Pentasaccharides for the prevention of venous thromboembolism.用于预防静脉血栓栓塞的五糖
Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD005134. doi: 10.1002/14651858.CD005134.pub3.
10
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.